Expertise in
8
conditions

Bruno Ranchin

Faculté De Médecine Lyon Est, 
Lyon, FR 
Expertise in
8
conditions
Faculté De Médecine Lyon Est, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Bruno Ranchin practices in Lyon, France. Mr. Ranchin is highly rated in 8 conditions, according to our data. His top areas of expertise are Autosomal Recessive Polycystic Kidney Disease, Chronic Kidney Disease, Diffuse Mesangial Sclerosis, Nephrotic Syndrome, and Kidney Transplant.

His clinical research consists of co-authoring 144 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Faculté De Médecine Lyon Est, Lyon, France
Other Locations
Groupement Hospitalier Est, Bron, 69500, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Comparison of Pre- and Post-dilution Hemodiafiltration Modalities - Effects on Biocompatibility and Solute Clearance in Children
Comparison of Pre- and Post-dilution Hemodiafiltration Modalities - Effects on Biocompatibility and Solute Clearance in Children
Enrollment Status: Unknown
Publish Date: August 22, 2023
Intervention Type: Device
Effect of Active Vitamin D and Etelcalcetide on Human Osteoclasts in Patients With Chronic Kidney Disease
Effect of Active Vitamin D and Etelcalcetide on Human Osteoclasts in Patients With Chronic Kidney Disease
Enrollment Status: Completed
Publish Date: March 31, 2020
Intervention Type: Other
An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre, Phase 3 Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent CKD Patients With Hyperphosphataemia
An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre, Phase 3 Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent CKD Patients With Hyperphosphataemia
Enrollment Status: Terminated
Publish Date: September 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

144 Total Publications

Addressing the crisis in paediatric dialysis: a call for urgent action.
Addressing the crisis in paediatric dialysis: a call for urgent action.
Journal: The Lancet. Child & adolescent health
Published: August 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ranchin's expertise for a condition
ConditionClose
    View All 39 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile